ANTONELLI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 5.127
EU - Europa 2.638
AS - Asia 1.091
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
Totale 8.879
Nazione #
US - Stati Uniti d'America 5.102
DE - Germania 741
CN - Cina 671
UA - Ucraina 552
PL - Polonia 544
HK - Hong Kong 184
IT - Italia 182
FI - Finlandia 142
RU - Federazione Russa 121
GB - Regno Unito 102
IE - Irlanda 97
SG - Singapore 96
FR - Francia 76
IN - India 50
BE - Belgio 39
VN - Vietnam 30
CA - Canada 22
TR - Turchia 21
IR - Iran 19
CZ - Repubblica Ceca 12
SE - Svezia 11
AU - Australia 9
EU - Europa 8
MY - Malesia 4
NL - Olanda 4
KR - Corea 3
MD - Moldavia 3
RO - Romania 3
AR - Argentina 2
BR - Brasile 2
ES - Italia 2
HU - Ungheria 2
JM - Giamaica 2
JP - Giappone 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
MX - Messico 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
Totale 8.879
Città #
Fairfield 780
Woodbridge 577
Warsaw 544
Ashburn 532
Jacksonville 445
Houston 368
Seattle 298
Ann Arbor 294
Cambridge 290
Wilmington 255
Chandler 244
Princeton 190
Hong Kong 184
Beijing 181
New York 117
Helsinki 107
Nanjing 103
Dublin 97
Dearborn 77
Nürnberg 59
Singapore 55
Brescia 48
Nanchang 48
Jinan 47
Des Moines 43
Shanghai 42
Shenyang 41
Brussels 36
Changsha 31
San Diego 31
Dong Ket 28
Hebei 27
Los Angeles 24
San Mateo 24
Jiaxing 22
Monmouth Junction 22
Washington 21
Tianjin 19
Ardabil 17
Hangzhou 16
Leawood 15
Milan 15
Toronto 15
Kunming 14
Lancaster 14
Verona 13
Hefei 12
Zhengzhou 12
Boardman 11
Frankfurt am Main 11
Lanzhou 11
Orange 11
Augusta 10
Brno 10
Kocaeli 9
London 8
Norwalk 8
Guangzhou 7
Munich 7
Ningbo 7
Romola 6
San Francisco 6
Sorgues 6
Taiyuan 6
Haikou 5
Prescot 5
Redwood City 5
Rome 5
Bologna 4
Canberra 4
Carmignano 4
Chiswick 4
Indiana 4
Phoenix 4
Taizhou 4
Changchun 3
Falkenstein 3
Fuzhou 3
Hanover 3
Islington 3
Kilburn 3
Melbourne 3
Mumbai 3
North York 3
Putte 3
Solbiate Olona 3
Acton 2
Amsterdam 2
Caravate 2
Castenedolo 2
Columbus 2
Gunzenhausen 2
Moscow 2
New Delhi 2
Philadelphia 2
Pisa 2
Riyadh 2
Sydney 2
Tiraspol 2
Tokyo 2
Totale 6.737
Nome #
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 254
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 244
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 169
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 162
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 153
Pros-IT CNR: an Italian prostate cancer monitoring project 147
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 144
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 140
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 135
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 128
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 126
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 124
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 122
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 121
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 121
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 120
Serum vitamin D and prostate cancer prognosis: The story continues 119
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 118
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 117
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 117
External histopathological validation of the surface-intermediate-base margin score 117
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 116
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 115
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 114
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 111
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 111
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 110
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 110
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 108
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 107
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 107
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 106
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 106
TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset 106
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 106
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 105
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 104
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 104
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. 102
NEPHRON SPARING SURGERY DOES NOT DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 102
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 101
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 99
Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project) 98
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 98
PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 96
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 95
RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 92
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 92
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: Perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). 91
Positive surgical margins and early oncological outcomes of robotic versus open radical prostatectomy at a medium case-load institution 90
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). 90
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 88
Prognostic role of tumour multifocality in renal cell carcinoma. 87
RALP CAN REDUCE THE RATE OF POSITIVE SURGICAL MARGIN: COMPARISON WITH OPEN PROSTATECTOMY IN A MEDIUM VOLUME CENTER 86
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 86
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project). 83
PERIOPERATIVE MORBIDITY OF CLAMP VERSUS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 82
WIDESPREAD PIN CAN PREDICT THE DIAGNOSIS OF PROSTATE CANCER AFTER A FIRST NEGATIVE RE-BIOPSY 81
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 79
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 79
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 79
OUTCOMES OF PREVENTIVE VS. DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: A RANDOMIZED TRIAL 79
HOW LONG SHOULD THE FOLLOW-UP BE EXTENDED AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW-UP 78
Clinical features and prognosis of patients with renal cancer and a second malignancy 78
END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE 77
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 75
ROBOT-ASSISTED RADICAL PROSTATECTOMY: LEARNING-CURVE AND CONTINENCE RATES 75
Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project 72
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 72
PIV-03 NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 72
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 72
Renal Cancer Follow-up Counterpoint: Europe 70
Cardiopulmonary bypass with brain perfusion for renal cell carcinoma with caval thrombosis 69
IMPACT OF GENDER IN NEPHRON-SPARING SURGERY: COMPARISON OF PERIOPERATIVE AND PATHOLOGICAL OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD1 PROJECT 68
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 66
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 66
PD49-06 THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE THE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 63
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "Midsummer Night's Dream" or "Much Ado About Nothing"? 63
HEAD-TO-HEAD EXTERNAL VALIDATION OF RENAL, PADUA, ABC SCORES AND C-INDEX IN NEPHRON SPARING SURGERY 62
NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 61
External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index 59
On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis 59
Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal carcinoma. 58
Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours 56
CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE 55
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 55
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 55
THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 52
PERIOPERATIVE COMPLICATIONS AFTER PARTIAL NEPHRECTOMY FOR COMPLEX (PADUA SCORE >= 10) RENAL TUMORS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD2 PROJECT) 51
POSITIVE SURGICAL MARGINS PREDICT PROGRESSION-FREE SURVIVAL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: RESULTS FROM A SINGLE CENTRE COHORT OF ALMOST 500 CASES WITH A MINIMUM FOLLOW_UP OF 5 YEARS 43
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 38
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 31
Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial 30
SURGICAL NOMOGRAM FOR PREDICTING THE LIKELIHOOD OF POSTOPERATIVE SURGICAL COMPLICATIONS IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY:APROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD 2 PROJECT) 29
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 24
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study 21
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma 17
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 11
A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 9
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 8
Totale 9.019
Categoria #
all - tutte 40.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.209 0 0 91 217 167 298 252 280 185 436 134 149
2020/20211.601 48 151 59 203 76 155 64 170 162 216 210 87
2021/2022771 96 95 19 22 14 44 29 50 47 96 56 203
2022/2023688 100 14 37 43 71 182 0 62 98 4 42 35
2023/2024976 51 19 72 100 58 229 24 48 203 26 9 137
2024/202537 13 14 10 0 0 0 0 0 0 0 0 0
Totale 9.064